Labeling and preliminary in vivo evaluation of the 5-HT7 receptor selective agonist [(11)C]E-55888

Research output: Contribution to journalJournal articleResearchpeer-review

Hanne D Hansen, Valdemar L Andersen, Szabolcs Lehel, Janus H Magnussen, Agnete Dyssegaard, Nikolas Stroth, Jesper Langgaard Kristensen, Gitte M Knudsen, Matthias M Herth

E-55888 has been identified as a selective serotonin 7 (5-HT7) receptor agonist. In this study, we describe the synthesis, radiolabeling and in vivo evaluation of [(11)C]E-55888 as a radioligand for positron emission tomography (PET) imaging. [(11)C]E-55888 was obtained by N-methylation of an appropriate precursor using [(11)C]MeOTf in acetone at 60°C giving isolated quantities in the range of 1.7-2.4GBq. Studies in Danish Landrace pigs demonstrated that [(11)C]E-55888 has good brain uptake, however, the distribution in the brain tissue was dominated by non-specific binding, as binding could neither be displaced by the structurally different 5-HT7 receptor ligand SB-269970 nor by self-block with unlabeled E-55888. Based on these data, [(11)C]E-55888 does not show promise as a PET radioligand for imaging the 5-HT7 receptor in vivo.

Original languageEnglish
JournalBioorganic & Medicinal Chemistry Letters
Volume25
Issue number9
Pages (from-to)1901-4
Number of pages4
ISSN0960-894X
DOIs
Publication statusPublished - 1 May 2015

ID: 136803379